These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3009518)

  • 1. Heat inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III.
    van Beers D; Duys M; Maes M; Biarent D; Haumont D
    J Virol Methods; 1985 Dec; 12(3-4):329. PubMed ID: 3009518
    [No Abstract]   [Full Text] [Related]  

  • 2. Heat inactivation of serum may interfere with HTLV-III/LAV serology.
    van den Akker R; Hekker AC; Osterhaus AD
    Lancet; 1985 Sep; 2(8456):672. PubMed ID: 2863663
    [No Abstract]   [Full Text] [Related]  

  • 3. Disinfection and inactivation of HTLV-III/LAV.
    Ronalds CJ; Grint PC; Kangro HD
    J Infect Dis; 1986 May; 153(5):996-7. PubMed ID: 3009641
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limitations of enzyme immunoassay tests for detection of HTLV-III/LAV antibodies.
    Lyons SF; McGillivray GM; Coppin AP; Schoub BD
    S Afr Med J; 1985 Oct; 68(8):575-6. PubMed ID: 2996159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test.
    Jungkind DL; DiRenzo SA; Young SJ
    J Clin Microbiol; 1986 Feb; 23(2):381-2. PubMed ID: 3009536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
    Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
    J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of eight ELISA kits for the detection of anti-LAV/HTLV-III antibodies.
    Courouce AM
    Lancet; 1986 May; 1(8490):1152-3. PubMed ID: 2871401
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a new assay for antibodies to LAV/HTLV III.
    Maskill W; Healey D; Wootten A; Silvester C; Johnson S; O'Dwyer C; Jacklin R; Pringle R; Gust I; Harden P
    J Virol Methods; 1986 Jul; 13(4):273-8. PubMed ID: 3018016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
    Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
    J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of confirmatory tests after strongly positive HTLV-III screening tests.
    Martin PW; Burger DR; Caouette S; Goldstein AS; Peetoom F
    N Engl J Med; 1986 Jun; 314(24):1577. PubMed ID: 3012336
    [No Abstract]   [Full Text] [Related]  

  • 14. [New evaluation of 3 immunoenzyme assay kits for the detection of anti-LAV antibodies].
    Rev Fr Transfus Immunohematol; 1986 Apr; 29(2):97-100. PubMed ID: 3018900
    [No Abstract]   [Full Text] [Related]  

  • 15. HTLV-III/LAV infection in hemodialysis patients.
    Peterman TA; Lang GR; Mikos NJ; Solomon SL; Schable CA; Feorino PM; Britz JA; Allen JR
    JAMA; 1986 May; 255(17):2324-6. PubMed ID: 3007792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
    De Rossi A; Gallo P; Tavolato B; Callegaro L; Chieco-Bianchi L
    Acta Neurol Scand; 1986 Aug; 74(2):161-4. PubMed ID: 3022528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTLV-III seropositivity in 1971-1972 parenteral drug abusers--a case of false positives or evidence of viral exposure?
    Moore JD; Cone EJ; Alexander SS
    N Engl J Med; 1986 May; 314(21):1387-8. PubMed ID: 3010112
    [No Abstract]   [Full Text] [Related]  

  • 18. Photometric reading of anti-HTLV-III ELISA kits.
    Grunnet N; Jersild C; Georgsen J
    Lancet; 1985 Dec; 2(8467):1302. PubMed ID: 2866361
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HTLV-III testing--a practical solution for blood transfusion services?
    Milner LV; Vorster BJ; Conradie JD; Brain P
    S Afr Med J; 1985 Dec; 68(13):921-2. PubMed ID: 3001948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.